Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
HIV Medicine Oct 07, 2019
Elvstam O, et al. - Longitudinal levels of plasma markers associated with inflammation, altered coagulation and cardiovascular disease were examined in Swedish HIV-positive adults in relation to low-level viraemia (LLV) or permanent virological suppression during long-term antiretroviral therapy (ART). Among 34 individuals with LLV (viral load 50–999 HIV-1 RNA copies/mL) vs matched controls with persistent virological suppression, researchers observed significantly higher levels of growth differentiation factor 15 [geometric mean 3,416 (95% confidence interval (CI) 804–14,516) pg/mL vs 2,002 (95% CI 355–11,295) pg/mL in controls] and D-dimer [mean 1,114 (95% CI 125–9,917) ng/mL vs 756 (95% CI 157–3,626) ng/mL] after adjustment for age, CD4 count nadir and type of ART. Based on the findings, they suggest a possible association between LLV and cardiovascular outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries